aTyr Pharma, Inc. Asset Resilience Ratio

Latest as of December 2025: 72.16%

aTyr Pharma, Inc. asset resilience ratio. aTyr Pharma, Inc. (ATYR) has an Asset Resilience Ratio of 72.16% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ATYR defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$67.94 Million

Cash + Short-term Investments

Total Assets

$94.16 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of aTyr Pharma, Inc. (2014–2025)

Asset resilience ratio of aTyr Pharma, Inc. from 2014 to 2025. This chart shows how aTyr Pharma, Inc.'s Asset Resilience Ratio has changed over time. Read ATYR liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down aTyr Pharma, Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of aTyr Pharma, Inc..

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$67.94 Million	72.16%
Total Liquid Assets	$67.94 Million	72.16%

Asset Resilience Insights

Very High Liquidity: aTyr Pharma, Inc. maintains exceptional liquid asset reserves at 72.16% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

aTyr Pharma, Inc. Industry Peers by Asset Resilience Ratio

Compare aTyr Pharma, Inc.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

aTyr Pharma, Inc. Asset Resilience Ratio by Year (2014–2025)

aTyr Pharma, Inc. asset resilience ratio by year from 2014 to 2025. The table below shows the annual Asset Resilience Ratio data for aTyr Pharma, Inc..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	72.16%	$67.94 Million	$94.16 Million	+9.09pp
2024-12-31	63.07%	$61.07 Million	$96.83 Million	+0.39pp
2023-12-31	62.68%	$75.62 Million	$120.65 Million	+4.04pp
2022-12-31	58.64%	$56.16 Million	$95.79 Million	-32.74pp
2021-12-31	91.38%	$105.58 Million	$115.54 Million	+53.32pp
2020-12-31	38.05%	$14.74 Million	$38.73 Million	-22.56pp
2019-12-31	60.61%	$21.93 Million	$36.19 Million	+10.21pp
2018-12-31	50.40%	$26.58 Million	$52.75 Million	-21.26pp
2017-12-31	71.66%	$64.03 Million	$89.36 Million	+29.73pp
2016-12-31	41.92%	$33.76 Million	$80.52 Million	+9.14pp
2015-12-31	32.78%	$42.51 Million	$129.68 Million	+23.32pp
2014-12-31	9.47%	$1.95 Million	$20.64 Million	--

pp = percentage points

About aTyr Pharma, Inc.

NASDAQ:ATYR USA Biotechnology

Market Cap

$650.08 Million

Market Cap Rank

#19292 Global

#4451 in USA

Share Price

$6.63

Change (1 day)

+5.41%

52-Week Range

$0.12 - $6.63

All Time High

$179.20